3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Renal Cell
84
Kidney Neoplasms
22
Prostatic Neoplasms
14
Neoplasm Metastasis
10
Neoplasms
9
Urinary Bladder Neoplasms
8
Carcinoma, Hepatocellular
5
Liver Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Pancreatic Neoplasms
3
Melanoma
3
Colorectal Neoplasms
3
Carcinoma
3
Urethral Neoplasms
2
Sarcoma
2
Multiple Myeloma
2
Hematologic Neoplasms
2
Glioblastoma
2
Financial Stress
2
Wilms Tumor
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombocytosis
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Germ Cell and Embryonal
1
Interventions
Gemcitabine
11
pembrolizumab
8
enfortumab vedotin
8
Specimen Handling
8
Cisplatin
8
Magnetic Resonance Spectroscopy
6
avelumab
5
Carboplatin
5
vinflunine
4
Nivolumab
4
atezolizumab
3
Biopsy
3
cabozantinib
2
Standard of Care
2
Ramucirumab
2
Platinum
2
Ipilimumab
2
Immunoglobulin G
2
Doxorubicin
2
Docetaxel
2
Disulfides
2
CTLA-4 Antigen
2
Bortezomib
2
1,2-diaminocyclohexaneplatinum II citrate
2
vandetanib
1
tocilizumab
1
tamibarotene
1
rucaparib
1
relatlimab
1
pegfilgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Sorafenib
×
Genitourinary
×
Clear all
NCT01844947
2019-04-26
VINSOR
Karolinska University Hospital
Phase 1
Completed
22 enrolled